Lorad Medical Systems and Fischer Imaging wielded charges andcountercharges last week during pretrial procedures for Fischer'sstereotactic-guided biopsy patent infringement suit (SCAN 4/8/92). Lorad fired the first public shot with release of a
Lorad Medical Systems and Fischer Imaging wielded charges andcountercharges last week during pretrial procedures for Fischer'sstereotactic-guided biopsy patent infringement suit (SCAN 4/8/92).
Lorad fired the first public shot with release of a statementthat Fischer Imaging has dropped two more of its patent claimsfiled against Lorad. Only two claims remain, down from the 16originally filed in April, Lorad said.
Withdrawing its patent claims one at a time is a way of droppingthe suit while saving face, according to Lorad.
"It's only a matter of time before this case is dismissed,"said Hal Kirshner, Lorad president.
Fischer countered with its own public statement discountingthe importance of the reduced number of claims. Narrowing thenumber of claims is common practice in patent suits as informationis reviewed during the discovery period, said Robert A. Cascella,executive vice president and CFO of Fischer.
Fischer initially cited five interrelated claims against Loradin its suit and reduced this to the two primary claims after reviewingLorad technical documentation, he said. These two claims, regardingelements of prone positioning, the stereotactic guided arm anddigital processing, had always been the essence of the patents,he said.
Lorad has made other claims about Fischer's image quality thatare not substantiated by comparative testing of the two systems,according to the Fischer statement. The company is consideringadditional nonpatent litigation against Lorad related to theseproduct claims, the company said.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.